Cancer medicines procured by the Punjab government are being distributed among hospitals and treatment centres to support patients receiving treatment.

Punjab Spends Over Rs5bn on Cancer Medicines

Thousands of Cancer Medicines Distributed Among Punjab Hospitals and Treatment Centres

By News Desk On Nov 11, 2026

LAHORE: (News Desk) – The Punjab government is spending more than Rs5 billion on the purchase of cancer medicines during the financial years 2025-26 and 2026-27 to ensure the availability of essential treatment for patients across the province.

According to sources, the government has initiated the procurement process for cancer medicines for the ongoing financial year 2026-27, with an estimated expenditure of Rs2.6 billion.

The medicines will be used to treat patients suffering from various types of cancer, including leukaemia, lymphoma, breast, colorectal and lung cancer.

Sources said some of the newly procured medicines would be supplied to patients after undergoing quality checks and receiving clearance from the Drug Testing Laboratory.

Meanwhile, eight cancer medicines purchased during the financial year 2025-26 have already been distributed among cancer treatment centres and government hospitals.

The supplied medicines include 5,016,560 tablets of Imatinib (100mg), 35,200 injections of Doxorubicin (50mg) and 21,880 injections of Paclitaxel (150mg).

Hospitals have also received 15,400 injections of Carboplatin (450mg) and 1,040 injections of Trastuzumab (440mg).

Furthermore, 1,486,912 doses of Nilotinib capsules have been distributed to hospitals for cancer patients.

The initiative aims to improve access to essential cancer medicines through government hospitals and reduce the financial burden on patients who otherwise face difficulties arranging expensive treatment.